"Emerging Market for Clinical Trials in Russia" Published

July 3, 2011 - PRLog -- Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player

Summary

GBI Research has released its latest report, 'Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player' that provides key data, information and analysis of the major trends and issues affecting the Clinical Trial market in Russia. The report provides a comprehensive insight of reasons for outsourcing clinical trials to Russia. The report also provides a detailed analysis of Russian clinical trial market structure. Analysis of major companies and countries which sponsor clinical trials in Russia is provided. Patient population analysis is done to highlight the types of diseased population available for conducting clinical trials in Russia. Opinion of industry experts has been incorporated in various parts of the report to emphasize the importance of various factors that affect the clinical trial market scenario in Russia.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/201052_emerging_market_for_cli...
------------------------------------------------------------

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research's team of industry experts.

Scope

The scope of the report includes -

* The need for outsourcing clinical trials to Russia
* Major companies and countries which sponsor clinical trials in Russia
* Trends in clinical trial registration in Russia
* Analysis of the key drivers and restraints that are impacting the growth of Clinical trial market in Russia
* Qualitative analysis of the key Infrastructural facilities present for conducting clinical trials in Russia
* Analysis of new federal law 'On circulation of medicine' and its impact on clinical trials market in Russia.
* Study of 11 key CROs operating in Russia.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

* Compare the key capabilities of major clinical trial service providers with your requirements and optimize your R&D costs
* Develop market entry and market expansion strategies by identifying the key drivers and challenges in Russian market
* Develop effective strategies to maximize the advantages in Russia through the understanding of the regulatory environment
* Understand the regulatory structure in Russia and key documents required to register clinical trial in Russia
* Gain knowledge about the major indications for which clinical trials can be conducted in Russia


Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Emerging Market for Clinical Trials in Russia - Introduction
2.1 GBI Research Report Guidance
3 Emerging Market for Clinical Trials in Russia - Overview
3.1 The Clinical Research Process - Overview
3.1.1 Drug Discovery Phase
3.1.2 Pre-Clinical Phase
3.1.3 Phase I
3.1.4 Phase II
3.1.5 Phase III
3.1.6 Review and Approval from the Regulatory Agencies
3.1.7 Post-marketing Studies
3.2 Clinical Trials in Russia - Market Overview
3.2.1 Major Countries Sponsoring Clinical Trials in Russia, 2008-2010 (Jan-June)
3.2.2 Major Companies Sponsoring Clinical Trials in Russia, 2009
3.2.3 Clinical Trials Conducted in Russia by Indication, 2009
3.3 Clinical Trial Market Structure in Russia
3.3.1 Clinical Trials Conducted in Russia by Study Type
3.3.2 Foreign Sponsored Clinical Trials Conducted in Russia by Phase
3.3.3 International Multicenter Clinical Trials Conducted in Russia, 2004-2009
3.3.4 Local Clinical Trials Conducted by Local Sponsors in Russia, 2004-2009
3.3.5 Bioequivalence Studies Conducted by Local Sponsors in Russia, 2004-2009
3.3.6 Local Clinical Trials Conducted by Foreign Sponsors in Russia, 2004-2009
3.3.7 Approved Foreign Clinical Trials in Russia, 2004- 2010 (Jan - June)
3.4 The Need for Outsourcing Clinical Trials
3.4.1 High Risks and Costs Associated With Drug Development
3.4.2 Escalating Costs of Clinical Trials
3.4.3 Global Increase in the Number of Clinical Trials Conducted
3.4.4 Restructuring the R&D
3.4.5 Increased Screening Rates during R&D
3.4.6 Expiring Patents Pressurize Pharmaceutical Companies to Reduce Costs
4 Emerging Market for Clinical Trials - Russia - Clinical Trial Trends
4.1 Registration of Phase l Clinical Trials
4.2 Registration of Phase lI Clinical Trials
4.3 Registration of Phase lII Clinical Trials
4.4 Registration of Phase lV Clinical Trials
4.5 Clinical Trials Registered in 2010
5 Market Environment Characterization
5.1 CRO Market in Russia, Market Forecast up to 2017
5.2 Market Drivers
5.2.1 Low Cost of Conducting Clinical Trials
5.2.2 High Patient Recruitment Rate
5.2.3 High Incidence rate of few Diseases as compared to other Countries
5.2.4 Availability of Drug-Naïve Patients
5.2.5 High Patient Compliance
5.2.6 Good In and Out-Patient Facilities
5.2.7 Presence of Experienced Investigators for Clinical Trials
5.2.8 Good Quality of Clinical Trial Data because Local GCP is identical to ICH GCP
5.3 Market Restraints
5.3.1 Increase in the Cost of Experienced Study Staff
5.3.2 Limited Experience of Newly Qualified Sites
5.3.3 Declining Population of Russia
6 Emerging Market for Clinical Trials - Russia, Health Statistics
6.1 Key Parameters of Russian Population
6.2 Characteristics of Active Trials in Russia
6.3 Patient Availability for Major Diseases
6.3.1 HIV-AIDS
6.3.2 Cancer
6.3.3 Diabetes
6.4 Tuberculosis (TB)
6.5 Mortality by Major Diseases in Russia
6.6 Medical Infrastructure in Russia
7 Regulatory Landscape
7.1 Documents to be Submitted for Clinical Trial Approval
7.2 Recent Regulatory Changes in Russia
7.3 Timelines for Getting Approval for Conducting Clinical Trials in Russia

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=2010...

About GBI Research

GBI Research provides industry-leading global business intelligence solutions. Their products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports each year across a wide range of industries. These reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from their expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia.  View more research from GBI Research at http://www.fastmr.com/catalog/publishers.aspx?pubid=1016

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.